TRxADE HEALTH (MEDS) Stock Price, News & Analysis

Company Overview

TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.

Key Stats

• Today's Range: $7.80 to $8.37
• 50-Day Range: $6.70 to $8.39
• 52-Week Range: $3.69 to $44.56
• Volume: 3,969 shs
• Average Volume: 207,831 shs
• Market Capitalization: $11.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MEDS Stock Analysis - Frequently Asked Questions

How have MEDS shares performed this year?

TRxADE HEALTH's stock was trading at $5.20 at the beginning of 2024. Since then, MEDS stock has increased by 55.8% and is now trading at $8.10.
View the best growth stocks for 2024 here.

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) issued its quarterly earnings results on Sunday, October, 24th. The company reported ($2.40) EPS for the quarter, missing the consensus estimate of ($1.95) by $0.45. The business had revenue of $2.55 million for the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 196.79% and a negative net margin of 149.81%.

When did TRxADE HEALTH's stock split?

TRxADE HEALTH's stock reverse split before market open on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include NVIDIA (NVDA), Communications Systems (JCS), Biora Therapeutics (BIOR), Paratek Pharmaceuticals (PRTK), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 10/24/2021
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:MEDS
• CUSIP: N/A
• CIK: 1382574
• Web: www.trxade.com
• Phone: (800) 261-0281
• Fax: 800-265-6932
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,840,000.00
• Net Margins: -149.81%
• Pretax Margin: -250.53%
• Return on Equity: -196.79%
• Return on Assets: -112.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.18
• Quick Ratio: 4.18

Sales & Book Value

• Annual Sales: $7.45 million
• Price / Sales: 1.53
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: 18.00

Miscellaneous

• Outstanding Shares: 1,406,000
• Free Float: 725,000
• Market Cap: $11.39 million
• Optionable: Not Optionable
• Beta: 2.32